Martin de Boer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Martin de Boer has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Karin van Leeuwen
University of Amsterdam
2 shared publications Anton T. J. Tool
Sanquin, Amsterdam, Netherlands
1 shared publicationArno van Heijst
Radboud University Medical Center, Nijmegen, Netherlands
1 shared publication- Arnon Broides
Soroka University Medical Center
1 shared publication Cathelijn C.E.M. Aarts
Sanquin Research, Amsterdam, Netherlands
1 shared publicationChristine W. Bruggeman
Sanquin Research, Amsterdam, Netherlands
1 shared publication
Latest Publications
- 11 June 2020
- Published by American Society of Hematology in Blood
- Vol. 135 (24) , 2171-2181
MKL1 deficiency results in a severe neutrophil motility defect due to impaired actin polymerization
Megakaryoblastic leukemia 1 (MKL1) promotes the regulation of essential cell processes, including actin cytoskeletal dynamics by co-activating serum response factor. Recently, the first human case with MKL1 deficiency, leading to a novel primary immunodeficiency, was identified. We report a second family with two siblings with a homozygous frameshift mutation in MKL1. The index case deceased as an infant from progressive and severe pneumonia by Pseudomonas aeruginosa and poor wound healing. The younger sib was preemptively transplanted shortly after birth. The immunodeficiency was marked by a pronounced actin polymerization defect and a strongly reduced motility and chemotactic response by MKL1-deficient neutrophils. Apart from the lack of MKL1, subsequent proteomic and transcriptomic analyses of patient neutrophils revealed actin and several actin-related proteins to be downregulated, confirming a role for MKL1 as transcriptional co-regulator. Degranulation was enhanced upon suboptimal neutrophil activation, while production of reactive oxygen species was normal. Neutrophil adhesion was intact but without proper spreading. The latter could explain the observed failure in firm adherence and transendothelial migration under flow conditions. No apparent defect in phagocytosis and bacterial killing was found. Also monocyte-derived macrophages showed intact phagocytosis; lymphocyte counts and proliferative capacity were normal. Non-hematopoietic primary patient fibroblasts demonstrated defective differentiation into myofibroblasts but normal migration and filamentous actin (F-actin) content, most probably due to compensatory mechanisms of MKL2, which is not expressed in neutrophils. Our findings extend current insight into the severe immune dysfunction in MKL1 deficiency, with cytoskeletal dysfunction and defective extravasation of neutrophils as most prominent features.
- 11 June 2020
- Published by American Society of Hematology in Blood
- Vol. 135 (24) , 2171-2181
MKL1 deficiency results in a severe neutrophil motility defect due to impaired actin polymerization
Megakaryoblastic leukemia 1 (MKL1) promotes the regulation of essential cell processes, including actin cytoskeletal dynamics by co-activating serum response factor. Recently, the first human case with MKL1 deficiency, leading to a novel primary immunodeficiency, was identified. We report a second family with two siblings with a homozygous frameshift mutation in MKL1. The index case deceased as an infant from progressive and severe pneumonia by Pseudomonas aeruginosa and poor wound healing. The younger sib was preemptively transplanted shortly after birth. The immunodeficiency was marked by a pronounced actin polymerization defect and a strongly reduced motility and chemotactic response by MKL1-deficient neutrophils. Apart from the lack of MKL1, subsequent proteomic and transcriptomic analyses of patient neutrophils revealed actin and several actin-related proteins to be downregulated, confirming a role for MKL1 as transcriptional co-regulator. Degranulation was enhanced upon suboptimal neutrophil activation, while production of reactive oxygen species was normal. Neutrophil adhesion was intact but without proper spreading. The latter could explain the observed failure in firm adherence and transendothelial migration under flow conditions. No apparent defect in phagocytosis and bacterial killing was found. Also monocyte-derived macrophages showed intact phagocytosis; lymphocyte counts and proliferative capacity were normal. Non-hematopoietic primary patient fibroblasts demonstrated defective differentiation into myofibroblasts but normal migration and filamentous actin (F-actin) content, most probably due to compensatory mechanisms of MKL2, which is not expressed in neutrophils. Our findings extend current insight into the severe immune dysfunction in MKL1 deficiency, with cytoskeletal dysfunction and defective extravasation of neutrophils as most prominent features.
- 9 August 2018
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 38 (6) , 638-641
p47phox-/- Chronic Granulomatous Disease Patient with Incomplete Kawasaki Disease
- 9 August 2018
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 38 (6) , 638-641
p47phox-/- Chronic Granulomatous Disease Patient with Incomplete Kawasaki Disease
- 1 December 2017
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 60 (12) , 643-649
Very early onset inflammatory bowel disease: Investigation of the IL-10 signaling pathway in Iranian children
- 1 December 2017
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 60 (12) , 643-649
Very early onset inflammatory bowel disease: Investigation of the IL-10 signaling pathway in Iranian children
- 21 May 2011
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 31 (4) , 560-566
Two X-Linked Chronic Granulomatous Disease Patients with Unusual NADPH Oxidase Properties
Chronic granulomatous disease (CGD) is an immune deficiency syndrome caused by defects in the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, the enzyme that generates reactive oxygen species (ROS) in phagocytizing leukocytes. This study evaluates the NADPH oxidase capacity in two X-linked CGD patients with mutations in gp91phox that alter the regions in this membrane-bound NADPH oxidase component involved in docking of the cytosolic component p47phox. Hydrogen peroxide and superoxide generation, bactericidal activity, and NADPH oxidase protein expression by the patients’ neutrophils were measured, and genetic analysis was performed. We report two patients, each with a novel missense mutation in CYBB, the gene that encodes gp91phox. Surprisingly, neutrophils from these patients showed total absence of superoxide production, although they retained 13–30% of the hydrogen peroxide production capability. We speculate that this is due to direct electron transfer from flavin adenine dinucleotide (FAD) in gp91phox to oxygen, leading to inefficient hydrogen peroxide formation instead of efficient superoxide production. X-linked CGD patients with mutations that alter the gp91phox protein in regions involved in docking of the cytosolic NADPH oxidase component p47phox may have higher than expected hydrogen peroxide generation capability.
- 21 May 2011
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 31 (4) , 560-566
Two X-Linked Chronic Granulomatous Disease Patients with Unusual NADPH Oxidase Properties
Chronic granulomatous disease (CGD) is an immune deficiency syndrome caused by defects in the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, the enzyme that generates reactive oxygen species (ROS) in phagocytizing leukocytes. This study evaluates the NADPH oxidase capacity in two X-linked CGD patients with mutations in gp91phox that alter the regions in this membrane-bound NADPH oxidase component involved in docking of the cytosolic component p47phox. Hydrogen peroxide and superoxide generation, bactericidal activity, and NADPH oxidase protein expression by the patients’ neutrophils were measured, and genetic analysis was performed. We report two patients, each with a novel missense mutation in CYBB, the gene that encodes gp91phox. Surprisingly, neutrophils from these patients showed total absence of superoxide production, although they retained 13–30% of the hydrogen peroxide production capability. We speculate that this is due to direct electron transfer from flavin adenine dinucleotide (FAD) in gp91phox to oxygen, leading to inefficient hydrogen peroxide formation instead of efficient superoxide production. X-linked CGD patients with mutations that alter the gp91phox protein in regions involved in docking of the cytosolic NADPH oxidase component p47phox may have higher than expected hydrogen peroxide generation capability.